+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019

  • ID: 4898182
  • Report
  • December 2019
  • Region: Global
  • 211 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Andramed GmbH
  • Boston Scientific Corp
  • Concept Medical Inc
  • eucatech AG
  • M.A. Med Alliance SA
  • Orchestra BioMed Inc
  • MORE
Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019“ provides an overview of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Andramed GmbH
  • Boston Scientific Corp
  • Concept Medical Inc
  • eucatech AG
  • M.A. Med Alliance SA
  • Orchestra BioMed Inc
  • MORE
1 Introduction
1.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Overview

2 Products under Development
2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
2.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Segment
2.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
2.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
2.5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
2.6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials

3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products under Development by Companies
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development

4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies and Product Overview
4.1 Andramed GmbH Company Overview
4.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.2 AnGes Inc Company Overview
4.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
4.3 AngioCure, Inc. Company Overview
4.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.4 Boston Scientific Corp Company Overview
4.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.5 Cagent Vascular LLC Company Overview
4.5.1 Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
4.6 Cardionovum GmbH Company Overview
4.6.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.7 Cardiovascular Systems Inc Company Overview
4.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
4.8 Concept Medical Inc Company Overview
4.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
4.9 Contego Medical LLC Company Overview
4.9.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
4.10 Endocor GmbH Company Overview
4.10.1 Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.11 eucatech AG Company Overview
4.11.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
4.12 Hexacath SA Company Overview
4.12.1 Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview
4.13 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
4.13.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.14 Lutonix Inc Company Overview
4.14.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
4.15 M.A. Med Alliance SA Company Overview
4.15.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
4.16 Medtronic plc Company Overview
4.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
4.17 Micell Technologies Inc Company Overview
4.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
4.18 MicroPort Endovascular (Shanghai) Co., Ltd. Company Overview
4.18.1 MicroPort Endovascular (Shanghai) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
4.19 NuVascular Technologies Inc Company Overview
4.19.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
4.20 Orchestra BioMed Inc Company Overview
4.20.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
4.21 Pulsus Medical LLC (Inactive) Company Overview
4.21.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.22 QT Vascular Ltd Company Overview
4.22.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.23 QualiMed Innovative Medizinprodukte GmbH Company Overview
4.23.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.24 SiL Vascular Ltd Company Overview
4.24.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.25 Spectranetics Corp Company Overview
4.25.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
4.26 SurModics Inc Company Overview
4.26.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
4.27 Tailored Medical Devices Inc Company Overview
4.27.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
4.28 TransMed7 LLC Company Overview
4.28.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
4.29 Vascular Nanotransfer Technologies Company Overview
4.29.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
4.30 Zhejiang Zylox Medical Device Co Ltd Company Overview
4.30.1 Zhejiang Zylox Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters- Recent Developments
5.1 Nov 22, 2019: Medtronic receives FDA approval for IN.PACT AV DCB
5.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
5.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
5.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors
5.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships

6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer

List of Tables
Table 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Table 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Segment
Table 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
Table 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
Table 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Table 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials
Table 7: PTA Balloons Catheters Companies - Pipeline Products by Stage of Development
Table 8: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Table 9: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Zero-Profile PTA Balloon - Product Status
Table 11: Zero-Profile PTA Balloon - Product Description
Table 12: AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
Table 14: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
Table 15: AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: AngioCure TOP-C Smart Balloon Catheter - Product Status
Table 17: AngioCure TOP-C Smart Balloon Catheter - Product Description
Table 18: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Athletis PTA Balloon - Product Status
Table 20: Athletis PTA Balloon - Product Description
Table 21: Drug Coated Balloon - Below-The-Knee (BTK) - Product Status
Table 22: Drug Coated Balloon - Below-The-Knee (BTK) - Product Description
Table 23: High Pressure Balloon - Venous Disease - Product Status
Table 24: High Pressure Balloon - Venous Disease - Product Description
Table 25: Next Generation 0.018” Balloon - Product Status
Table 26: Next Generation 0.018” Balloon - Product Description
Table 27: Ranger Drug-Coated Balloon - Product Status
Table 28: Ranger Drug-Coated Balloon - Product Description
Table 29: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 30: Ranger Drug-Coated Balloon - A Randomized Trial Comparing Drug-coated Balloon and Regular Balloon for Dialysis Access Stent Graft Restenosis
Table 31: Ranger Drug-Coated Balloon - Clinical Study of the Boston Scientific Paclitaxel-coated PTA (Percutaneous Transluminal Angioplasty) Balloon Catheter (Ranger and Ranger SL (OTW) DCB) in China
Table 32: Ranger Drug-Coated Balloon - JETStream AtheRectomy with Adjunctive Paclitaxel-coated Balloon Angioplasty Versus Balloon Angioplasty Followed by Paclitaxel-coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease: JET-RANGER
Table 33: Ranger Drug-Coated Balloon - Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
Table 34: Ranger Drug-Coated Balloon - Prospective, Randomized, Multicenter Clinical Study of the Hemoteq Ranger Paclitaxel-coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions
Table 35: Ranger Drug-Coated Balloon - RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
Table 36: Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Serranator Bass - Product Status
Table 38: Serranator Bass - Product Description
Table 39: Cagent Vascular LLC - Ongoing Clinical Trials Overview
Table 40: Serranator Bass - Prospective Study for the Treatment of Atherosclerotic Lesions in the Infrapopliteal Arteries Using the Serranator Device: PRELUDE BTK (Below The Knee) Study
Table 41: Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 42: APERTO OTW - Product Status
Table 43: APERTO OTW - Product Description
Table 44: Cardionovum GmbH - Ongoing Clinical Trials Overview
Table 45: APERTO OTW - A Randomized Trial of Aperto Paclitaxel Eluting Dilatation Catheter Compared to POBA in Dialysis Fistula
Table 46: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Peripheral PTA Balloon Catheter - Product Status
Table 48: Peripheral PTA Balloon Catheter - Product Description
Table 49: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: MagicTouch PTA Balloon Catheter - Product Status
Table 51: MagicTouch PTA Balloon Catheter - Product Description
Table 52: Concept Medical Inc - Ongoing Clinical Trials Overview
Table 53: MagicTouch PTA Balloon Catheter - A Pilot Study to Evaluate the Safety and Efficacy of MagicTouch PTA Sirolimus Coated Balloon for the Treatment of Below-the-Knee (BTK) Lesions
Table 54: Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Superficial Femoral Artery Balloon - Product Status
Table 56: Superficial Femoral Artery Balloon - Product Description
Table 57: Tibial Artery Drug Eluting Balloon - Product Status
Table 58: Tibial Artery Drug Eluting Balloon - Product Description
Table 59: Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Endorenal - Product Status
Table 61: Endorenal - Product Description
Table 62: eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Support - Product Status

List of Figures
Figure 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Figure 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Segment
Figure 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
Figure 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
Figure 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Figure 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Andramed GmbH
  • AnGes Inc
  • AngioCure, Inc.
  • Boston Scientific Corp
  • Cagent Vascular LLC
  • Cardionovum GmbH
  • Cardiovascular Systems Inc
  • Concept Medical Inc
  • Contego Medical LLC
  • Endocor GmbH
  • eucatech AG
  • Hexacath SA
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Lutonix Inc
  • M.A. Med Alliance SA
  • Medtronic plc
  • Micell Technologies Inc
  • MicroPort Endovascular (Shanghai) Co., Ltd.
  • NuVascular Technologies Inc
  • Orchestra BioMed Inc
  • QT Vascular Ltd
  • QualiMed Innovative Medizinprodukte GmbH
  • SiL Vascular Ltd
  • Spectranetics Corp
  • SurModics Inc
  • Tailored Medical Devices Inc
  • TransMed7 LLC
  • Vascular Nanotransfer Technologies
  • Zhejiang Zylox Medical Device Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll